Prograf ® (tacrolimus) – Expanded indication
July 16, 2021 - The FDA approved Astellas Pharma’s Prograf (tacrolimus), for the prophylaxis of organ rejection, in adult and pediatric patients receiving lung transplant in combination with other immunosuppressants.
Download PDF
